Cargando…
Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time
BACKGROUND: The dose and dosing time of indocyanine green (ICG) vary among fluorescence cholangiography (FC) studies. The purpose of this prospective, randomized, exploratory clinical trial was to optimize the dose and dosing time of ICG. METHODS: PubMed was searched to determine the optimal dose. T...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437885/ https://www.ncbi.nlm.nih.gov/pubmed/33026517 http://dx.doi.org/10.1007/s00464-020-08058-6 |
_version_ | 1783752249904726016 |
---|---|
author | Chen, Qiangxing Zhou, Rou Weng, Jiefeng Lai, Yueyuan Liu, Hui Kuang, Jiao Zhang, Shuai Wu, Zhaofeng Wang, Wen Gu, Weili |
author_facet | Chen, Qiangxing Zhou, Rou Weng, Jiefeng Lai, Yueyuan Liu, Hui Kuang, Jiao Zhang, Shuai Wu, Zhaofeng Wang, Wen Gu, Weili |
author_sort | Chen, Qiangxing |
collection | PubMed |
description | BACKGROUND: The dose and dosing time of indocyanine green (ICG) vary among fluorescence cholangiography (FC) studies. The purpose of this prospective, randomized, exploratory clinical trial was to optimize the dose and dosing time of ICG. METHODS: PubMed was searched to determine the optimal dose. To optimize the dosing time of ICG, a clinical trial was designed with two parts. The first part included patients with T tubes for more than 1 month. After the patient was injected with ICG, bile was collected at 10 time points to explore the change and trends of bile fluorescence intensity (FI). In addition, the results of the first experiment were used to setup a randomized controlled trial (RCT) that aimed to find the optimal dosing timing for ICG injections for laparoscopic cholecystectomy (LC). During surgery, imaging data were collected for analysis. RESULTS: After performing a systematic review, the ICG injection dose for each patient in the clinical trial was 10 mg. Five patients were included in the first part of the study. Bile collected 8 h after ICG injection had a higher FI than bile collected at other time points (p < 0.05), and the FI of bile collected 20 h after ICG injection was nearly zero. In the second part of the experiment, 4 groups of patients (6 patients per group) were injected with 10 mg ICG at 8, 10, 12 and 14 h prior to surgery. The distribution of bile duct FI (p = 0.001), liver FI (p < 0.001), and common bile duct (CBD)-to-liver contrast (p = 0.001) were not the same in each group. Further analysis with the Bonferroni method revealed the following: (1) the FI of the CBD in the 8 h group was significantly different from that in the 14 h group (adjusted p < 0.001); (2) the liver FI of the 8 h group was higher than that of the 10 h group (adjusted p = 0.042) and the 14 h group (adjusted p < 0.001); and (3) the CBD-to-liver contrast of the 8 h group was lower than that of the 10 h group (adjusted p = 0.013) and the 14 h group (adjusted p = 0.001). CONCLUSION: ICG FC enables the real-time identification of extrahepatic bile ducts. The optimal effect of FC can be achieved by performing 10 mg ICG injections 10 to 12 h prior to surgery. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00464-020-08058-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8437885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84378852021-09-29 Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time Chen, Qiangxing Zhou, Rou Weng, Jiefeng Lai, Yueyuan Liu, Hui Kuang, Jiao Zhang, Shuai Wu, Zhaofeng Wang, Wen Gu, Weili Surg Endosc Article BACKGROUND: The dose and dosing time of indocyanine green (ICG) vary among fluorescence cholangiography (FC) studies. The purpose of this prospective, randomized, exploratory clinical trial was to optimize the dose and dosing time of ICG. METHODS: PubMed was searched to determine the optimal dose. To optimize the dosing time of ICG, a clinical trial was designed with two parts. The first part included patients with T tubes for more than 1 month. After the patient was injected with ICG, bile was collected at 10 time points to explore the change and trends of bile fluorescence intensity (FI). In addition, the results of the first experiment were used to setup a randomized controlled trial (RCT) that aimed to find the optimal dosing timing for ICG injections for laparoscopic cholecystectomy (LC). During surgery, imaging data were collected for analysis. RESULTS: After performing a systematic review, the ICG injection dose for each patient in the clinical trial was 10 mg. Five patients were included in the first part of the study. Bile collected 8 h after ICG injection had a higher FI than bile collected at other time points (p < 0.05), and the FI of bile collected 20 h after ICG injection was nearly zero. In the second part of the experiment, 4 groups of patients (6 patients per group) were injected with 10 mg ICG at 8, 10, 12 and 14 h prior to surgery. The distribution of bile duct FI (p = 0.001), liver FI (p < 0.001), and common bile duct (CBD)-to-liver contrast (p = 0.001) were not the same in each group. Further analysis with the Bonferroni method revealed the following: (1) the FI of the CBD in the 8 h group was significantly different from that in the 14 h group (adjusted p < 0.001); (2) the liver FI of the 8 h group was higher than that of the 10 h group (adjusted p = 0.042) and the 14 h group (adjusted p < 0.001); and (3) the CBD-to-liver contrast of the 8 h group was lower than that of the 10 h group (adjusted p = 0.013) and the 14 h group (adjusted p = 0.001). CONCLUSION: ICG FC enables the real-time identification of extrahepatic bile ducts. The optimal effect of FC can be achieved by performing 10 mg ICG injections 10 to 12 h prior to surgery. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00464-020-08058-6) contains supplementary material, which is available to authorized users. Springer US 2020-10-07 2021 /pmc/articles/PMC8437885/ /pubmed/33026517 http://dx.doi.org/10.1007/s00464-020-08058-6 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Chen, Qiangxing Zhou, Rou Weng, Jiefeng Lai, Yueyuan Liu, Hui Kuang, Jiao Zhang, Shuai Wu, Zhaofeng Wang, Wen Gu, Weili Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title | Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title_full | Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title_fullStr | Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title_full_unstemmed | Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title_short | Extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
title_sort | extrahepatic biliary tract visualization using near-infrared fluorescence imaging with indocyanine green: optimization of dose and dosing time |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437885/ https://www.ncbi.nlm.nih.gov/pubmed/33026517 http://dx.doi.org/10.1007/s00464-020-08058-6 |
work_keys_str_mv | AT chenqiangxing extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT zhourou extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT wengjiefeng extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT laiyueyuan extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT liuhui extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT kuangjiao extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT zhangshuai extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT wuzhaofeng extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT wangwen extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime AT guweili extrahepaticbiliarytractvisualizationusingnearinfraredfluorescenceimagingwithindocyaninegreenoptimizationofdoseanddosingtime |